Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study The challenge of focusing only on erectile function is ...
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study Patient-reported outcomes after radical prostatectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback